Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate. Costa PA, Espejo-Freire AP, Fan KC, Albini TA, et al. Leuk Lymphoma 2022;63:239-242.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Costa PA, Espejo-Freire AP, Fan KC, Albini TA, et al. Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate. Leuk Lymphoma 2022;63:239-242.
PMID: 34514943